CHIEF EXECUTIVE Delivering Strategic Leadership in Life Science and High Technology
Seasoned CEO with strong portfolio of success leading the strategic development of technology innovation in the pharmaceutical, biotechnology, and life sciences industries. Instrumental in launching, developing, and significantly enhancing the bottom-line profitability of a well-known supplier of software & research products & services. Adept at cultivating relationships with and presenting to investors, investment banks, analysts, and shareholders. Familiar with corporate governance, SEC rules, and public company reporting. Ph.D. in Biochemistry. Areas of expertise:
Strategic Planning • Business Development • Mergers & Acquisitions • New Product Development
Opportunity Identification • Investor & Stakeholder Relations • Strategic Alliances • Negotiations
Budget Administration & P&L Accountability • Executive Presentations & Public Speaking
Capital Fundraising • Executive & Board Recruitment • Business Analysis
PROFESSIONAL EXPERIENCE
Private Company • 2008 - Present
Provider of software for scientific research in life sciences and other industries. Revenues: $50M
Consultant, Business Strategy
Recruited by and reporting to the CEO on a full-time basis to identify new business opportunities, merger and acquisition opportunities, and providing management guidance for strategic product groups.
Public Company • 1994-2007
Provider of software & research products & services to pharmaceutical, biotechnology, and other life science organizations to aid in the discovery of new therapeutics; $65M annual revenue at peak.
President & CEO
Reported to Board of Directors, and led all corporate strategic planning and business development. Administered $20M capital and $35M operating budgets. Supervised 7 Senior VPs. Directly managed international operations including subsidiaries in England, France, Germany and distributors in the Pacific Rim. Evaluated new product strategies and concepts and investment opportunities. Drove efforts to expand market share and increase bottom line. Cultivated partnerships for joint ventures, collaborative marketing, investments, and academic collaborations. Maintained investor, investment bank, and analyst relations. Led acquisition & integration initiatives. Raised investment capital. Delivered conference presentations. Served as primary customer liaison.
Key Contributions:
• Drove efforts to boost revenues from $20M in 1994 to $65M at company peak in 2004. During this same period, Company’s market capitalization grew from less than $15M to more than $330M.
• Initiated joint venture in 1995 to design and sell chemical collections to the pharmaceutical industry; efforts generated $18M in revenue in 2 years.
• Led $1.5M founding investment in Biotechnology Company that returned $17M within 6 years.
• Invested $0.4M founding capital in BioTools Company with return of $1M in two years.
• Spearheaded the acquisition of a UK-based chemistry company that generated new business, including a $90M, 4-year contract with a major international pharmaceutical company for the development of novel chemicals.
• Secured $14M service contract with Bayer Pharmaceuticals by initiating collaboration with a bio tool provider to produce leading-edge pharmaceutical research information systems.
• Established relationship with Accenture that ultimately resulted in a joint offering and collaborative marketing between the Company and Accenture; The Company subsequently entered software development projects with Bristol-Myers Squibb (~$5M), Merck (~$2M), Schering AG (~$5M), and Wyeth (~$6M) between 2000 and 2006.
• Recruited and assembled a Board of Directors subsequent to the Company’s spin-out as an independent public company in 1994; board was comprised of financial experts, a Nobel-prizewinning scientist, and the principal scientific discoverer of Merck's blockbuster drugs Mevacor® and Zocor®.
• Led search in 2006 for strategic alternatives that resulted in sale of Company's business ops in 2007.
Formal Recognition:
• Honored with Ernst & Young Entrepreneur of the Year award for science and technology in the St. Louis region on behalf of the Company in 2002.
Private Company, Subsidiary of Computer Company • 1987-1994
Acquired by Computer Company in 1987, a pioneer in high-performance graphics and computing; established as an independent subsidiary; $1M annual revenue in 1987.
President
Reported to CEO of Computer Company, and assumed P&L accountability for Subsidiary. Oversaw all financial, sales & marketing, and R&D operations. Led business-critical software development initiatives. Established European operations for sales and support in England, France, Germany and engaged and managed Pacific Rim distributor and support network. Played integral role in parent company executive management and maintained all key customer and collaborative relationships. Networked with industry leaders, and delivered presentations at major conferences.
Key Contributions:
• Grew revenue from $1M to $20M by investing in new technologies and scientific techniques that established the Subsidiary as a leader in an extremely competitive marketplace.
• Initiated and executed the acquisition of a NY-based software company; restructured and integrated company to enable new capabilities that boosted revenue 25% and significantly expanded customer base.
• Established a collaborative commercial consortium to fund the development of an innovative database searching technology; orchestrated academic collaborations to produce leading-edge scientific software.
• Recruited company’s first experienced commercial sales manager, a sales executive from Digital Equipment Corporation, who transformed the organization from a group of technical representatives to a high-performance, professional sales operation.
• Recommended the spinout of Subsidiary as an independent public company.
CAREER NOTE: Background includes prior roles as Head of Software R&D for Subsidiary prior to acquisition by Computer Company.
(Developed the initial product architecture that serves as the foundation of all the Company's software) and as Research Scientist for a Major University's Medical School & Engineering School (Developed operating system, utilities, and scientific software that were integral part of the start-up of the Company.)
(Additional details available upon request.)
EDUCATION & TRAINING
Ph.D. in Biochemistry
University of Wisconsin, Madison, Wisconsin
Bachelor of Science in Chemistry
Tarleton State University, Stephenville, Texas
Finance for Executives, Strategic Acquisitions & Alliances (The Kellogg School, Northwestern University)
Pharmacology & Pharmacokinetics (Kemic Bioresearch Labs)
AFFILIATIONS
American Chemical Society
American Crystallographic Association |
